Becton Dickinson & Co. closed 32.13% below its 52-week high of $251.99, which the company reached on February 3rd.

Becton Dickinson receives multiple downgrades as analysts cite weakening organic growth and trimmed price targets following a ...

Shares of Becton, Dickinson (NYSE:BDX) traded sharply lower on Thursday after the medical equipment maker lowered its ...

We recently published a list of 11 Best Falling Stocks to Buy According to Analysts. In this article, we are going to take a ...

Becton, Dickinson and Company ( NYSE: BDX) Bank of America Securities Health Care Conference Call May 13, 2025 1:00 PM ET Tom Polen - Chairman, Chief Executive Officer and President ...

A mistrial was declared Tuesday after jurors awarded a retired truck driver a total of $70 million in his lawsuit against the owner of a Covington sterilization facility.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Even though Becton, Dickinson and Company (NYSE:BDX) posted strong earnings, investors appeared to be underwhelmed. We have done some analysis and have found some comforting factors beneath the ...

"Jeff is a visionary leader with a strong track record of driving global success in the life sciences and medical device industries," said Jay Katzen, Executive Chairman, Fotona. "We are excited to ...

Shares of Becton Dickinson & Co. BDX rose 1.20% to $167.14 Wednesday, on what proved to be an all-around great trading ...

The most notable increase was in Becton Dickinson & Co (NYSE:BDX), with an additional 1,091,690 shares, bringing the total to 5,517,712 shares. This adjustment represents a significant 24.67% ...

The latest price target for Becton Dickinson (NYSE:BDX) was reported by Morgan Stanley on May 6, 2025. The analyst firm set a price target for $196.00 expecting BDX to rise to within 12 months (a ...